Salute e Benessere
Pediatric Cardiology Market to Reach US$ 6.5 Billion by 2034, Fueled by Rising Prevalence of Congenital Heart Disorders (CHD) and Surgical Interventions |TMR
The increase in the prevalence of congenital heart disorders (CHD) is driving the pediatric cardiology devices market. It is estimated that about one-third of babies born with CHD require some form of intervention early in life, with the majority needing open-heart surgery.
The global pediatric cardiology market is expected to grow considerably, driven by technological advancements, improved healthcare infrastructure, and supportive government policies. Innovations in minimally invasive procedures, catheter-based therapies, and heart transplant programs underscore the importance and complexity of treating congenital heart diseases in pediatrics.
Focusing on CHDs in pediatric cardiology not only addresses a critical need but also propels advancements in medical technologies and treatment protocols that benefit a wide range of patients. Funding for research and development in paediatric cardiology has also increased significantly, promoting innovation and the development of new diagnostic and treatment procedures. Nonprofit organisations play an important role in this environment by promoting awareness, sponsoring research, and assisting families impacted by paediatric cardiac diseases.
Organizations such as the American Heart Association and the British Heart Foundation perform substantial outreach and educational initiatives to educate the general public and healthcare practitioners on the importance of CHD screening and management. These organisations also promote policy reforms and improved funding for paediatric cardiology research.
Despite significant progress in medical diagnosis and intervention, challenges remain in the care of patients with CHD. These challenges affect not only patients but also cardiac surgeons, general cardiologists, and CHD specialists. Additionally, compared to high-income countries, there are far fewer comprehensive pediatric heart centers capable of performing infant and newborn heart surgeries in low- and middle-income countries, posing a significant challenge for the growth of the pediatric cardiology market over the forecast period.
Focusing on CHDs in pediatric cardiology not only addresses a critical need but also propels advancements in medical technologies and treatment protocols that benefit a wide range of patients. Funding for research and development in paediatric cardiology has also increased significantly, promoting innovation and the development of new diagnostic and treatment procedures. Non-profit organisations play an important role in this environment by promoting awareness, sponsoring research, and assisting families impacted by paediatric cardiac diseases.
Organizations such as the American Heart Association and the British Heart Foundation perform substantial outreach and educational initiatives to educate the general public and healthcare practitioners on the importance of CHD screening and management. These organisations also promote policy reforms and improved funding for paediatric cardiology research.
Despite significant progress in medical diagnosis and intervention, challenges remain in the care of patients with CHD. These challenges affect not only patients but also cardiac surgeons, general cardiologists, and CHD specialists. Additionally, compared to high-income countries, there are far fewer comprehensive pediatric heart centers capable of performing infant and newborn heart surgeries in low and middle-income countries, posing a significant challenge for the growth of the pediatric cardiology market over the forecast period.
From engaging in collaborative partnerships to launching new products, players in the global pediatric cardiology market hope to secure a substantial revenue share in forthcoming years. Characterized by the presence of various prominent players, the industry is significantly competitive.
Players such as Medtronic, and Edwards Lifesciences, are investing in research and development activities to launch innovative catheter technologies. Their objective is to meet the growing demands of the market, as the number of pediatric patients needing interventional cardiology procedures continues to rise.
Some of the prominent pediatric cardiology market players profiled in the report are as follows:
, a global market research company registered at Wilmington, Delaware , United States , provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
:
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
+1-518-618-1030
: 866-552-3453
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/pediatric-cardiology-market-to-reach-us-6-5-billion-by-2034--fueled-by-rising-prevalence-of-congenital-heart-disorders-chd-and-surgical-interventions-tmr-302204313.html